Dr. Roxana Timmermans

In an era where AI is transforming industries, this session delves into its role in reinforcing the bonds of trust and collaboration critical to pharma contract manufacturing partnerships. We'll discuss how AI not only complements but elevates the partnership dynamics between CMOs and pharmaceutical companies by providing advanced insights, optimizing operations, and facilitating more effective communication. The presentation will highlight the synergistic potential of combining AI's analytical prowess with the irreplaceable human elements of mutual respect, open dialogue, and aligned objectives.

Key takeaways:

• Enhancing Partnership Synergy: How AI tools and analytics can deepen understanding, predict trends, and tailor strategies in CMO collaborations.
• Innovating Together: Leveraging AI to transcend traditional transactional relationships, fostering a culture of joint innovation and long-term value.
• Cultivating a Collaborative Ecosystem: The critical role of AI in supporting an environment of trust, transparency, and mutual success in the pharma sector.

In this next session, we break into groups to evaluate the approaches discussed at this year’s event. What conclusions can we draw on the best ways forward on key challenges? Topics for discussion are:

• BEST PRACTICE IN SELECTING EXTERNAL PARTNERS
• ENSURING TRANSPARENT & EFFECTIVE COLLABORATIONS
• ALIGNING EVOLVING BUSINESS NEEDS WITH PARTNERS
• DEFINING KEY SUCCESS FACTORS IN 2024 & BEYOND